Market Research Logo

Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals and health and wellbeing products. It offers expert advice on health and wellbeing and quality products through pharmacies. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola’s brands. It also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD also maintains partnerships with other pharma companies to distribute several drugs in Finland, Sweden, Estonia, Latvia, Lithuania and Russia. Oriola-KD is headquartered in Espoo, Finland.

Oriola-KD Oyj Key Recent Developments

Oct 25,2017: Oriola: Interim Report January-September 2017
Oct 12,2017: Oriola third quarter result impacted by distribution disruptions in Finland
Jul 21,2017: Oriola's Half Year Financial Report January-June 2017
Jul 13,2017: Oriola revises guidance for continuing operations adjusted operating profit
Jul 07,2017: Changes in Oriola's Group Management Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent Developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Oriola-KD Oyj - Key Facts
Oriola-KD Oyj - Key Employees
Oriola-KD Oyj - Key Employee Biographies
Oriola-KD Oyj - Major Products and Services
Oriola-KD Oyj - History
Oriola-KD Oyj - Company Statement
Oriola-KD Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Oriola-KD Oyj - Business Description
Oriola-KD Oyj - Corporate Strategy
Oriola-KD Oyj - SWOT Analysis
SWOT Analysis - Overview
Oriola-KD Oyj - Strengths
Oriola-KD Oyj - Weaknesses
Oriola-KD Oyj - Opportunities
Oriola-KD Oyj - Threats
Oriola-KD Oyj - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Oriola-KD Oyj, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 25, 2017: Oriola: Interim Report January-September 2017
Oct 12, 2017: Oriola third quarter result impacted by distribution disruptions in Finland
Jul 21, 2017: Oriola's Half Year Financial Report January-June 2017
Jul 13, 2017: Oriola revises guidance for continuing operations adjusted operating profit
Jul 07, 2017: Changes in Oriola's Group Management Team
Jun 22, 2017: Oriola has rearranged its long-term revolving credit facility and term loan agreement
Apr 28, 2017: Oriola Interim Report for 1 January – 31 March 2017
Feb 13, 2017: Oriola-KD's Financial Statements Release 2016
Oct 20, 2016: Oriola-KD Interim Report for 1 January-30 September 2016
Sep 07, 2016: Terhi Kivinen Appointed Group Communications Director, Oriola-Kd Corporation
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Oriola-KD Oyj, Key Facts
Oriola-KD Oyj, Key Employees
Oriola-KD Oyj, Key Employee Biographies
Oriola-KD Oyj, Major Products and Services
Oriola-KD Oyj, History
Oriola-KD Oyj, Subsidiaries
Oriola-KD Oyj, Key Competitors
Oriola-KD Oyj, Ratios based on current share price
Oriola-KD Oyj, Annual Ratios
Oriola-KD Oyj, Annual Ratios (Cont...1)
Oriola-KD Oyj, Annual Ratios (Cont...2)
Oriola-KD Oyj, Interim Ratios
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Oriola-KD Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Oriola-KD Oyj, Performance Chart (2012 - 2016)
Oriola-KD Oyj, Ratio Charts
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report